KRAS Mutation in Uterine Corpus Endometrial Carcinoma

Oncogene

KRAS mutations occur in approximately 19% of Uterine Corpus Endometrial Carcinoma cases. Explore survival impact, morphological differences, and co-occurring mutations below.

KRAS in Other Cancer Types

Pancreatic Adenocarcinoma 64% Colon Adenocarcinoma 48% Rectum Adenocarcinoma 38% Lung Adenocarcinoma 30% Uterine Carcinosarcoma 11% Stomach Adenocarcinoma 8% Thyroid Carcinoma 6% Cholangiocarcinoma 6% Cervical Squamous Cell Carcinoma 5%

Other Mutations in Uterine Corpus Endometrial Carcinoma

PTEN 67% PIK3CA 50% ARID1A 44% TP53 38% EGFR 7%

Explore Further

Uterine Corpus Endometrial Carcinoma Atlas KRAS Pan-Cancer Overview All Mutations